The PSCI is delighted to welcome Energize as an official PSCI partner to support the acceleration of renewable energy adoption and enable bold climate action within the pharmaceutical sector supply chain.
In 2021, ten PSCI member companies launched a potentially game-changing collaboration to increase access to renewable energy for the pharma supply chain via the Energize Program. This first-of-its-kind industry program will enable suppliers – who may not otherwise have the internal resources or expertise available – to both learn more about and participate in the market for power purchase agreements (PPAs). The program will help pharmaceutical and healthcare suppliers to address their own operational Scope 2 greenhouse gas emissions through green power procurement, which in turn will reduce the participating companies’ Scope 3 emissions.
Renewable energy procurement can be challenging for companies of all sizes for a variety of reasons. The Energize program is designed to overcome typical market barriers such as inadequate knowledge about renewable energy transactions, load size, lack of credit, and the need for guidance throughout a complex and protracted contracting process. Participating suppliers will learn about the renewable energy market, receive guidance on PPAs, and have the opportunity to access and contract for renewable energy on their own or as part of a collaborative buyers’ cohort.
Speaking on the partnership, Rob Williams, Director - Procurement Sustainability at Astrazeneca and Co-lead of the PSCI Decarbonization Team says,
"Decarbonizing the pharma supply chain is a huge undertaking that requires partnership and collaboration. I’m delighted that the PSCI and Energize are working together to support the whole of the pharma sector supply chain through a shared value approach. By raising awareness about the world of renewable energy and providing a platform and solution for the pharma companies and their suppliers to decarbonize, we are making the transition to net zero a reality for the sector.”
John Powers, VP, Renewable Energy & Cleantech, Schneider Electric Sustainability Business says,
"We’re delighted to work together with PSCI and its member companies to accelerate the path to decarbonization through Energize – our unique, first-of-its-kind program designed for pharmaceutical and healthcare suppliers. Together, we’re enabling a more collaborative approach to Scope 3 decarbonization by helping suppliers engage renewable energy via power purchase agreements (PPAs) and meaningfully impacting the total pharma value chain.”
You can find out more about the partnership in this webinar recording presented by the PSCI and Energize teams (available to those registered with the PSCI).
The Energize program is designed and delivered by Schneider Electric; the pharmaceutical companies promote the program collectively, and individually invite their suppliers to participate. Current corporate members include Amgen, AstraZeneca, Biogen, Bristol Myers Squibb, Boehringer Ingelheim, Chiesi, GSK, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, Takeda, Teva Pharmaceuticals, and UCB.